10x, Harvard settle genomics patent dispute with Vizgen during trial
Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...
10x Genomics, Inc. (TXG): Among Cathie Wood’s Top Stock Picks for 2025
We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...
10x Genomics price target lowered to $18 from $19 at Barclays
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
news.stocktradersdaily2d
(TXG) Investment Analysis and Advice
Check the time stamp on this data. Updated AI-Generated Signals for 10x Genomics Inc. (TXG) available here: TXG. Type a few ...
Seattle's Parse Biosciences lands another legal victory in patent dispute
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
ETF Daily News7d
10x Genomics’ (TXG) “Sell (E+)” Rating Reiterated at Weiss Ratings
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reiterated by analysts at Weiss Ratings in a research note issued to investors on Saturday,Weiss Ratings reports.
Cathie Wood’s ARK Investment buys 250K shares of 10x Genomics today
EST Cathie Wood’s ARK Investment buys 250K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...
Yahoo Finance4d
10x Genomics, Inc. (TXG): Among Cathie Wood’s Top Stock Picks for 2025
In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks in Cathie Wood's portfolio. Cathie Wood is one of Wall Street's most ...